
|
World Health Organization, Geneva, Switzerland |
| |
|

|
Ministry of Health, The People’s Republic of China |
| |
|

|
State Drug Administration, The People’s Republic of China |
| |
|

|
Department of Health, The Government of the Hong Kong Special Administrative Region of The People’s Republic of China |
This document is not issued to the general public, and all rights are reserved by the World Health Organization (WHO). The document may not be reviewed, abstracted, quoted, reproduced or translated, in part or in whole, without the prior written permission of WHO. No part of this document may be stored in a retrieval system or transmitted in any form or by any means - electronic, mechanical or other - without the prior permission of WHO.
The views expressed in documents by named authors are solely the responsibility of those authors.
Objectives of the International Conference of Drug Regulatory Authorities:
• To promote collaboration between drug regulatory authorities
• To reach a consensus on matters of interest
• To facilitate timely and adequate exchange of information
• To discuss issues of international relevance